| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/23/2004 | US20040185510 Administering a composition sufficient for external imaging, a peptide of given formula; radioactive scanning or by magnetic resonance; use for detecting metastasis; kits |
| 09/23/2004 | US20040185465 for diagnosing a disease in an animal or susceptibility to a disease related to an over-expression of a phosphodiesterase; for drug screening antiinflammatory agents |
| 09/23/2004 | US20040185044 Use of human antibody which recognises apolipoprotein CIII; atherosclerosis or dyslipidaemia treatment; passive vaccination |
| 09/23/2004 | US20040185038 loss of immunogenicity is achieved by amino acid substitution, addition or deletion, conducted at a position which in the non-modified polypeptide remains uncleaved by a protease of the MHC class II proteolytic pathway |
| 09/23/2004 | US20040185033 Tumor antigens and CTL clones isolated by a novel procedure |
| 09/23/2004 | CA2518889A1 Methods of radiofluorination of biologically active vectors |
| 09/22/2004 | EP1458748A2 Apoptotically active peptides |
| 09/22/2004 | EP1458747A1 Template-fixed peptidomimetics as inhibitors of serine proteases |
| 09/22/2004 | EP1458745A2 SUBSTITUTED AMINO CARBOXAMIDES FOR THE TREATMENT OF ALZHEIMER'S DISEASE |
| 09/22/2004 | EP1163264B1 Novel lhrh antagonists with improved solubility characteristics |
| 09/22/2004 | EP1100520B1 Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
| 09/22/2004 | EP0938500B1 INTERLEUKIN-1beta-CONVERTING ENZYME (ICE) INHIBITING PEPTIDES |
| 09/22/2004 | EP0866800B1 Antineoplastic peptides |
| 09/22/2004 | CN1531550A Heterocarpine, human GHRH-binding protein |
| 09/22/2004 | CN1531441A Pharmaceutical compositinos which inhibit vascular proliferation and method of use thereof |
| 09/21/2004 | US6794545 Conformationally restricted polyamine analogs as disease therapies |
| 09/21/2004 | US6794490 Lipopeptides as antibacterial agents |
| 09/21/2004 | US6794489 Peptide sequence ac-nle-cyclo(-asp-his-d-phe-arg-trp-lys)-oh derived from a melanocyte-stimulating hormone (? alpha -msh?) analog, called melanotan-ii |
| 09/21/2004 | US6794364 Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
| 09/21/2004 | US6794361 Conotoxin polypeptide inhibits neuronal amine transporters; incontinence, cardiovascular disorders |
| 09/21/2004 | US6794358 Binds urokinase plasminogen activator receptor and inhibits binding to integrin; cancer, chronic inflammation, and cell migration treatment; medical diagnosis |
| 09/21/2004 | US6793925 Pseudomycin natural products |
| 09/21/2004 | CA2420184C Conotoxins |
| 09/16/2004 | WO2004079371A1 Diagnosis of autism |
| 09/16/2004 | WO2004078933A2 Intracellular delivery of small molecules proteins and nucleic acids |
| 09/16/2004 | WO2004078779A2 Conopeptides and methods of use |
| 09/16/2004 | WO2004078778A2 PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF |
| 09/16/2004 | WO2004078146A2 Trans-membrane-antibody induced inhibition of apoptosis |
| 09/16/2004 | WO2004078098A2 Peptides associated with hla-dr mhc class ii molecules involved in autoimmune diseases |
| 09/16/2004 | WO2004064709A3 Thrombolytic agent |
| 09/16/2004 | WO2004062556A3 Methods for preventing and treating alzheimer’s disease (ad) |
| 09/16/2004 | WO2004052916A3 Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids |
| 09/16/2004 | WO2004047762A3 Methods for treating cancer using porimin as a target |
| 09/16/2004 | WO2004033482A3 Phenolic binding peptides |
| 09/16/2004 | WO2003106615A3 Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation |
| 09/16/2004 | WO2003062265A3 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 09/16/2004 | WO2003053457A8 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon |
| 09/16/2004 | WO2002069691A3 Immunogenic hiv peptides for use as reagents and vaccines |
| 09/16/2004 | US20040181054 Process for producing sugar chain asparagine derivative |
| 09/16/2004 | US20040181034 Multimeric Apo A-I agonist compounds |
| 09/16/2004 | US20040181033 Binding agents which inhibit myostatin |
| 09/16/2004 | US20040181032 for promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
| 09/16/2004 | US20040180835 Use of the protein uk114 or of fragments thereof for the treatment and prevention of the endotoxic shock |
| 09/16/2004 | US20040180415 Isolating fusion protein comprised of metal affinity peptide using immobilized metal ion affinity chromatography (IMAC) |
| 09/16/2004 | US20040180395 Method for detecting calpain3 activity in a biological sample and peptides for implementing said method |
| 09/16/2004 | US20040180354 Comprises polypeptides which are displayable on antigen presenting cells of immune system for use in prevention and treatment of infection and vaccine development; immunotherapy |
| 09/16/2004 | US20040180038 Effectors of innate immunity determination |
| 09/16/2004 | CA2518187A1 Peptides associated with hla-dr mhc class ii molecules involved in autoimmune diseases |
| 09/16/2004 | CA2518119A1 Trans-membrane-antibody induced inhibition of apoptosis |
| 09/16/2004 | CA2517939A1 Peptides that specifically bind hgf receptor (cmet) and uses thereof |
| 09/16/2004 | CA2516677A1 Intracellular delivery of small molecules proteins and nucleic acids |
| 09/15/2004 | EP1456662A2 Detection of auto-antibodies from patients suffering from rheumatoid arthritis |
| 09/15/2004 | EP1456382A2 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 09/15/2004 | EP1456239A2 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 09/15/2004 | EP1456229A2 Method for preparing echinocandin derivatives |
| 09/15/2004 | EP1455808A1 Phosphinate-peptide analogues as inhibitors of procollagen-c-proteinase (pcp) for treating fibrotic diseases |
| 09/15/2004 | EP1032708A4 Nucleic acid ligands of tissue target |
| 09/15/2004 | EP1007095B1 CHIMERIC TOXINS COMPRISING GnRH FOR TARGETED THERAPY |
| 09/15/2004 | EP0970106B1 uPAR-MIMICKING PEPTIDES |
| 09/15/2004 | EP0938326B1 Synthetic phosphopeptides for treating bone diseases |
| 09/15/2004 | EP0837881B1 CONJUGATES OF alpha-MSH WITH A FATTY ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG |
| 09/15/2004 | EP0714404B1 Anti-inflammatory peptides |
| 09/15/2004 | CN1529714A Modified interfron alpha with reduced immunogenicity |
| 09/15/2004 | CN1166690C Hepatitis C inhibitor peptides |
| 09/15/2004 | CN1166683C New BPC peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
| 09/15/2004 | CN1166682C Bacteriocidal/permeation enhanced protein functional area bioactive pipetide |
| 09/15/2004 | CN1166597C Nitrogenous group conversion method |
| 09/14/2004 | US6790941 Zinc finger protein derivatives and methods therefor |
| 09/14/2004 | US6790938 Human autoantibodies and antiidiotypic antibodies against blood platelet membrane proteins |
| 09/14/2004 | US6790935 Cyclosporin derivatives and method for the production of said derivatives |
| 09/14/2004 | US6790830 Use of 3-position cyclosporin derivatives for hair growth |
| 09/14/2004 | US6790829 Cyclic decapeptide antibiotics |
| 09/14/2004 | US6790633 Prevents binding of ras protein in malignant cells |
| 09/14/2004 | US6790447 Peptides for treatment of autoimmune diseases |
| 09/10/2004 | WO2004076487A1 Antibody and use thereof |
| 09/10/2004 | WO2004076478A1 PEPTIDE DERIVATIVES HAVING β-SECRETASE INHIBITORY ACTIVITY |
| 09/10/2004 | WO2004076473A2 Androgen receptor interacting peptides |
| 09/10/2004 | WO2004075910A1 Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis |
| 09/10/2004 | WO2004075843A2 Glycosolated enkephalin agents |
| 09/10/2004 | WO2004058803A3 Peptides that bind of the vegfr-2 |
| 09/10/2004 | WO2004058799A3 Methods and compositions for inhibiting binding of ige to a high affinity receptor |
| 09/10/2004 | WO2004031210A3 Optimized multi-epitope constructs and uses thereof |
| 09/10/2004 | WO2004020579A3 Method of humanizing immune system molecules |
| 09/10/2004 | WO2003099842A3 Compositions and methods of use for a bombesin peptide |
| 09/10/2004 | WO2003093300A3 Anti-microbial peptides and compositions |
| 09/10/2004 | WO2003087092A3 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease |
| 09/10/2004 | WO2002099045A3 Peptide beta-strand mimics based on 1,2-dihydro-3(6h)-pyridinone |
| 09/10/2004 | CA2515975A1 Peptide derivatives having .beta.-secretase inhibitory activity |
| 09/10/2004 | CA2507527A1 Glycosolated enkephalin agents |
| 09/09/2004 | US20040176578 Amino acid sequences capable of associating with fluorophore dyes for use as diagnostic tools in vitro and invivo detection and assay systems |
| 09/09/2004 | US20040176303 Isolated mollusc amino acid sequence having hydroxyvaline and tryptophan in contiguous residues; modulation of ion levels in cells |
| 09/09/2004 | US20040176302 Methods for inhibiting tumor cell proliferation |
| 09/09/2004 | US20040176300 No hemolytic activity; having leucine in place of tryptophan; synthesizing peptide sequences |
| 09/09/2004 | US20040176285 Tip39 polypeptides |
| 09/09/2004 | US20040176284 1,2-Dithio-5,8,11,14,17-pentaazocycloeicosane derivatives |
| 09/09/2004 | US20040176283 Methods and compositions for the design of synthetic vaccines |
| 09/09/2004 | US20040176280 Carbohydrate-specific peptides which have a strong affinity and preparations method thereof |
| 09/09/2004 | US20040175365 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 09/09/2004 | DE10308107A1 New macrocyclic peptide derivatives useful for treating bacterial infections, especially caused by Gram-positive bacteria |
| 09/08/2004 | EP1454914A1 Tumor antigen |